Letters

Clinical and economic arguments favour extension to upper age limit for breast screening

BMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7147.1829 (Published 13 June 1998) Cite this as: BMJ 1998;316:1829
  1. David J Torgerson, Senior research fellow,
  2. Toby Gosden, Research fellow
  1. National Primary Care Research and Development Centre, Centre for Health Economics, University of York, York YO1 5DD
  2. National Primary Care Research and Development Centre, University of Manchester, Manchester M13 9PL

    EDITOR—In an editorial Sutton argues that the upper age limit of 64 for breast screening is illogical, and he ascribes it to ageism.1 This may be true, but there is no economic rationale for limiting routine screening to women below the age of 65. Indeed, the most cost effective age in terms of cost per life year saved by breast screening is 70.2 We have recently set out …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe